Document is current

Any future updates will be listed below

Safinamid bei Morbus Parkinson in allen Altersgruppen wirksam und verträglich

Crossref DOI link: https://doi.org/10.1007/s15202-022-4922-8

Published Online: 2022-08-01

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark